Regular review is needed for medicines optimisation

This is the third in a series of articles highlighting points raised in the King’s Fund report on polypharmacy. This article highlights issues relating to medicines optimisation.

Regular review is needed for medicines optimisation

Add yours ↓
Web design and marketing agency Leamington Spa